Lingotto Investment Management LLP / TEVA
Lingotto Investment Management LLP’s Teva Pharmaceutical Inds Ltd Position
Does Lingotto Investment Management LLP own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 27.77M shares worth $836M (+16.52% of its 13F portfolio) as of Q1 2026, down from 28.42M shares the prior filed quarter.
Position Value
$836M
Q1 2026
Shares
27.77M
% of Portfolio
+16.52%
Quarters Held
15
currently held
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 27.77M | $836M | +16.52% |
| Q4 2025 | 28.42M | $887M | +15.46% |
| Q3 2025 | 57.18M | $1.2B | +10.67% |
| Q2 2025 | 28.16M | $472M | +10.03% |
| Q1 2025 | 27.85M | $428M | +11.18% |
| Q4 2024 | 27.19M | $599M | +16.08% |
| Q3 2024 | 26.50M | $478M | +13.77% |
| Q2 2024 | 26.46M | $430M | +14.45% |
| Q1 2024 | 26.42M | $373M | +15.61% |
| Q4 2023 | 34.46M | $360M | +17.32% |
| Q3 2023 | 33.85M | $345M | +18.51% |
| Q2 2023 | 24.21M | $182M | +11.78% |
| Q1 2023 | 17.09M | $151M | +10.83% |
| Q4 2022 | 15.01M | $94M | +7.05% |
| Q3 2022 | 11.52M | $93M | +8.56% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lingotto Investment Management LLP’s full portfolio or all institutional holders of TEVA.